Nerve growth factor against PTSD symptoms: Preventing the impaired hippocampal cytoarchitectures

Prog Neurobiol. 2020 Jan:184:101721. doi: 10.1016/j.pneurobio.2019.101721. Epub 2019 Nov 5.

Abstract

Although exogenous nerve growth factor (NGF) demonstrated great potential for post-traumatic stress disorder (PTSD) treatment, its therapeutic effect and underlying cytological mechanism were not fully elucidated so far. We employed a controlled, prospectively designed modified single prolonged stress mice model to investigate the role of exogenous NGF on the modified single prolonged stress induced PTSD-like symptoms and hippocampal cytoarchitecture impairment, as well as the potential neuronal signaling modulation. We discovered that the modified single prolonged stress-exposure induced significant PTSD-like symptoms as well as mildly impaired hippocampal Cornu Ammonis 1 (CA1) subregion cytoarchitecture, but not dentate gyrus neurogenesis, together with a gradual inhibition of TrkA-CREB-ERK signalings in hippocampal CA1 subregion. NGF treatment dose-dependently ameliorated the modified single prolonged stress induced PTSD-like symptoms. NGF increased the cytoplasm/nucleus ratio and improved the neuronal plasticity, mainly via the TrkA-ERK-CREB pathway. Our study offered the translational evidence for the potential application of exogenous NGF for treating or early preventing PTSD after stress exposure.

Keywords: Hippocampal CA1 subregion; NeuronJ; Sholl analysis; Single prolonged stress; Synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • CA1 Region, Hippocampal / cytology
  • CA1 Region, Hippocampal / drug effects*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Disease Models, Animal
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Growth Factor / administration & dosage
  • Nerve Growth Factor / pharmacology*
  • Neuronal Plasticity / drug effects*
  • Pyramidal Cells / drug effects*
  • Receptor, trkA / metabolism
  • Signal Transduction / drug effects*
  • Stress Disorders, Post-Traumatic / drug therapy*

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Nerve Growth Factor
  • Receptor, trkA